CVS Health (CVS) Price Target Boosted by $8 at Mizuho

America’s starring wellness solutions company, CVS Health Corporation (NYSE:CVS) provides precocious wellness attraction from pharmacy services and wellness plans to wellness and wellness.

On May 20, Mizuho bumped up its terms people connected CVS Health Corporation (NYSE:CVS) from $102 to $110, portion maintaining an ‘Outperform’ standing connected the shares. The people boost represents an upside of implicit 17% from the existent stock price.

Mizuho believes that the managed attraction radical delivered beardown results successful the caller Q1 net season. The steadfast boosted its people connected CVS owed to the little hazard of antagonistic aesculapian nonaccomplishment ratio changes done the extremity of this year.

Similarly, earlier connected May 8, Wells Fargo besides raised its terms people connected CVS Health Corporation (NYSE:CVS) by $1 and kept an ‘Overweight’ standing connected the shares (read much details here).

The affirmative expert attraction comes aft CVS delivered better-than-expected results for its Q1 connected May 6. Moreover, the institution raised its full-year 2026 nett guidance to a scope of $7.30 to $7.50 per share, up from its forecast of $7 to $7.20. CVS present expects its full-year full revenues to beryllium astatine slightest $405 billion, portion its currency travel from operations is projected to beryllium astatine slightest $9.5 billion.

While we admit the imaginable of CVS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Top 12 Undervalued Dividend Stocks to Buy Now and 12 Best Blue Chip Dividend Stocks to Buy Now

Disclosure: None. Follow Insider Monkey connected Google News.